APP and Alzheimer disease: The amyloid hypothesis that the generation of toxic Aβ from amyloid precursor protein (APP) and Aβ aggregation result in the pathophysiological changes associated with AD (Figure 1) led to compounds targeting Aβ (Karran et al., 2011; Eisele et al., 2015).